Deerfield Beach, FL -- (SBWIRE) -- 06/19/2017 -- Latest industry research report on Dilated Cardiomyopathy Market. Dilated cardiomyopathy (DCM) results from heart enlargement. It is a fetal cardiac disorder, where heart walls become weak and heart fails to pump blood efficiently. It could have negative impact on lungs, liver and other important organs due to improper supply of blood. Left ventricle is the major pumping chamber that can be initially affected in cardiomyopathy causing its enlargement. The other symptoms of cardiomyopathy include irregular heartbeats, blood clots and valve problems. Male individuals are more prone to cardiomyopathy than female individuals. The causes for dilated cardiomyopathy are genetic defects, infections, birth defects, certain cancer medications, drug and alcohol abuse and exposure to toxic metals.

Get Free Sample Report Of Dilated Cardiomyopathy Market @ http://www.marketresearchstore.com/report/asia-pacific-dilated-cardiomyopathy-market-opportunities-and-71375#RequestSample

The available treatments focus to improve the blood flow of heart, which is the primary leads to cardiomyopathy.

The Asia-pacific market for dilated cardiomyopathy is segmented into two broad categories such as treatment types and geography.

BY TREATMENT TYPES

Therapeutics
Angiotensin-converting enzyme (ACE) inhibitors
Beta blockers
Aldosterone antagonists
Digitalis
Angiotensin II receptor blockers
Anticoagulants
Therapy Devices (Implantable Devices)
Implantable cardioverter-defibrillators (ICDs)
Biventricular pacemakers
Heart pumps

MARKET BY GEOGRAPHY

China
Japan
India
Indonesia
Singapore
Other

Do Inquiry To Buy Report Of Dilated Cardiomyopathy Market @ http://www.marketresearchstore.com/report/asia-pacific-dilated-cardiomyopathy-market-opportunities-and-71375#InquiryForBuying